Dr. Joshua O. Podjasek, MD

Dr. Podjasek practices at Dermatology Associates of La Grange in Lagrange, Illinois.

Dr. Podjasek's NPI, 1245496850, was assigned on August 3, 2008. Dr. Podjasek graduated from Rush Medical College of Rush University in 2008. Dr. Podjasek holds Illinois license 036.133122.

Dr. Podjasek's primary practice is Dermatology Associates of La Grange, at 5201 S Willow Springs Rd- Suite 440, Lagrange, IL 60525. The practice phone is (708) 482-3213.

Dr. Podjasek's primary practice is Dermatology Associates of La Grange in Lagrange, Illinois. The medical group on file is Dermatology Associates of La Grange. Dmand AI also links Dr. Podjasek to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Podjasek's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Podjasek practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Podjasek's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Podjasek's licenses on file in 2 states: Illinois and Minnesota.

CMS data shows 13,678 Medicare services from Dr. Podjasek across 34 procedure codes in 2024, for 3,215 Medicare patients. Medicare paid $815,928 for them. Every service was in an office.

CMS counts 3,215 Medicare patients who saw Dr. Podjasek in 2024. The largest group is 65 to 74, with 1,540 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Podjasek's median patient age at 64, with 53% women.

In 2024, Dr. Podjasek wrote 1,611 Medicare Part D claims for 664 patients. 95% of them were for generic drugs. CMS names the drug for 1,429 of them, across 19 drugs with 11 or more claims each, at $35,945 in total drug cost. In 2023, CMS named 1,221 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Podjasek for performance year 2024, reported as part of a group. Dr. Podjasek accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,452 procedures of removal of skin lesions by Dr. Podjasek, more than 96% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Podjasek, published from 2010 to 2015. 2010 was the busiest year, with 3. The most frequent topics are Dermatitis, Allergic Contact, Patch Tests and Biopsy. Dr. Podjasek has published most often in Int J Dermatol. Dr. Podjasek's most frequent co-authors are Brook Elan Tlougan, MD, Robert H. Cook-Norris, MD and Brian B. Adams, MD.

CMS Open Payments shows 458 general payments to Dr. Podjasek from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Abbvie Inc. paid the most, $2,541.

Dr. Podjasek graduated from Rush Medical College of Rush University in 2008.